Dermata Therapeutics
Encinitas
About Dermata Therapeutics
Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists. Its business strategy is to identify and develop innovative products that move into clinical trials to demonstrate efficacy and safety in a variety of diseases. They currently exploring the use of a unique botanical product with multiple proposed mechanisms of action in order to treat acne. It was founded in 2014 and headquartered in Encinitas, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10M+
- Total funding: $41.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:DRMA
- Website: dermatarx.com
- Phone: +1 858-756-2480
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dermata-therapeutics-82350 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.